<p>Aveanna Healthcare Holdings (AVAH) 的股票在公司第三季度更新后引起了关注，该更新展示了显著的收入和 EBITDA 增长。公司还报告了重新盈利的情况。管理层在这些结果的基础上提高了全年收入指引。</p>
<p>查看我们对 Aveanna Healthcare Holdings 的最新分析。</p>
<p>在其乐观的财报发布后，Aveanna 的势头显然加速了。尽管本周略有回调，但该股年初至今的股价回报率为 94%，而其三年总股东回报率为 810%，使得长期收益备受瞩目。近期的战略举措，如收购、债务再融资和指引提升，在增强投资者对未来增长和运营稳定性的信心方面发挥了关键作用。</p>
<p>如果 Aveanna 的激增让你关注下一个医疗行业赢家，可以通过我们的最新分析发现其他行业佼佼者，查看完整名单，免费获取。</p>
<p>然而，随着 Aveanna 股价的显著上涨和指引的提升，投资者不禁想知道，考虑到其增长轨迹，目前的估值是否真的便宜，还是市场已经将所有的上涨空间都考虑在内。</p>
<h2>最受欢迎的叙述：低估 9%</h2>
<p>最受欢迎的叙述表明，Aveanna Healthcare Holdings 的公允价值为 9.61 美元，略高于其最后收盘价 8.75 美元。这为深入探讨可能推动乐观分析师预测的因素奠定了基础。</p>
<blockquote>
<p><em>成功执行优先支付者战略，包括在所有细分市场快速增加优先支付者协议以及在费率提升方面的立法进展，支持更高的报销率、更好的运营杠杆和改善的净利润率，直至 2025 年及以后。</em></p>
</blockquote>
<p>阅读完整叙述。</p>
<p>想要了解是什么推动了这个大胆的估值吗？最受关注的假设是利润和利润率的多年度提升，这依赖于战略变化和一个重要的人口趋势。未来三年的蓝图是什么样的？只有完整的叙述才能揭示这些预期如何转化为未来的现金流和估值。</p>
<p><strong>结果：公允价值为 9.61 美元（低估）</strong></p>
<p>完整阅读叙述，了解预测背后的原因。</p>
<p>然而，持续的工资通胀或对医疗保险和医疗补助的监管压力仍可能威胁到 Aveanna 的利润扩张和长期增长前景。</p>
<p>了解影响 Aveanna Healthcare Holdings 叙述的关键风险。</p>
<h2>另一种观点：市场倍数暗示了什么？</h2>
<p>从另一个角度看，Aveanna 的市盈率为 24.2 倍，虽然高于美国医疗行业平均水平 21.5 倍，但仍远低于同行平均水平 81.6 倍。有趣的是，该股的公允倍数估计为 33.5 倍，如果乐观情绪持续，市场可能会向这一水平转变。这为投资者提供了估值风险和机会的混合，提出了一个问题：Aveanna 的盈利增长是否能证明向该公允倍数靠近的合理性？</p>
<p>查看数字对这一价格的看法——在我们的估值分析中了解更多。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bc590ca0-25cc-402c-81a6-671b1cea62d8/chart/pe-multiple-vs-industry?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bc590ca0-25cc-402c-81a6-671b1cea62d8/chart/pe-multiple-vs-industry"/></p>
<p>NasdaqGS:AVAH 截至 2025 年 11 月的市盈率</p>
<h2>构建您自己的 Aveanna Healthcare Holdings 叙述</h2>
<p>如果您对这个故事有不同的看法，或者想要测试自己的观点，您可以在不到三分钟的时间内从相同的数据集中构建个性化叙述，按您的方式进行。</p>
<p>进行 Aveanna Healthcare Holdings 研究的一个很好的起点是我们的分析，强调了 2 个关键奖励和 1 个重要警示信号，这可能会影响您的投资决策。</p>
<h2>寻找更多投资想法？</h2>
<p>聪明的投资者知道机会不会等待。使用 Simply Wall Street 筛选器来精准定位具有突出品质的股票，这些股票可能会推动您的投资组合上涨。</p>
<ul>
<li>通过针对这些 881 只低估股票来解锁利润潜力，这些股票基于现金流被市场忽视，尽管它们的现金流和基本面强劲。</li>
<li>通过这些 16 只收益率超过 3% 的股息股票来提升您的被动收入策略，这些股票提供可靠的收益和强健的财务健康。</li>
<li>通过跟踪这些 25 只 AI 小盘股，抢占明天的科技趋势，这些公司在人工智能和自动化的前沿进行创新。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也不考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 对提到的任何股票没有持仓。</em></p>

AVAH

<p>Aveanna Healthcare Holdings (AVAH) 公布了强劲的第三季度业绩，显示出显著的收入和 EBITDA 增长，并恢复了盈利能力。该公司上调了全年收入指引，导致年初至今的股价回报率达到 94%。分析师建议的公允价值为 9.61 美元，表明该股票在最后收盘价 8.75 美元时被低估。Aveanna 的市盈率为 24.2 倍，高于行业平均水平，但低于同行。主要风险包括工资通胀和对医疗保险和医疗补助的监管压力，这可能会影响未来的增长</p>

<p>Aveanna Healthcare Holdings (AVAH) shares drew attention following the company’s third quarter update, which showcased sharp revenue and EBITDA growth. The company also reported a move back into profitability. Management raised full-year revenue guidance in light of these results.</p>
<div class="lb-trans"><p>Aveanna Healthcare Holdings (AVAH) 的股票在公司第三季度更新后引起了关注，该更新展示了显著的收入和 EBITDA 增长。公司还报告了重新盈利的情况。管理层在这些结果的基础上提高了全年收入指引。</p>
</div><p>See our latest analysis for Aveanna Healthcare Holdings.</p>
<div class="lb-trans"><p>查看我们对 Aveanna Healthcare Holdings 的最新分析。</p>
</div><p>Following its upbeat earnings, Aveanna's momentum has clearly accelerated. Despite a slight pullback this week, the stock’s year-to-date share price return of 94% stands out, while its three-year total shareholder return of 810% puts longer-term gains firmly in the spotlight. Recent strategic moves such as acquisitions, debt refinancing, and guidance raises have played a key role in building investor confidence around future growth and operational stability.</p>
<div class="lb-trans"><p>在其乐观的财报发布后，Aveanna 的势头显然加速了。尽管本周略有回调，但该股年初至今的股价回报率为 94%，而其三年总股东回报率为 810%，使得长期收益备受瞩目。近期的战略举措，如收购、债务再融资和指引提升，在增强投资者对未来增长和运营稳定性的信心方面发挥了关键作用。</p>
</div><p>If Aveanna’s surge has you watching for the next healthcare winner, discover other industry standouts with our latest See the full list for free.</p>
<div class="lb-trans"><p>如果 Aveanna 的激增让你关注下一个医疗行业赢家，可以通过我们的最新分析发现其他行业佼佼者，查看完整名单，免费获取。</p>
</div><p>Yet with Aveanna’s remarkable share price rally and upgraded guidance, investors are left wondering if the current valuation is a bargain given its growth trajectory, or if the market has already priced in all the upside.</p>
<div class="lb-trans"><p>然而，随着 Aveanna 股价的显著上涨和指引的提升，投资者不禁想知道，考虑到其增长轨迹，目前的估值是否真的便宜，还是市场已经将所有的上涨空间都考虑在内。</p>
</div><h2>Most Popular Narrative: 9% Undervalued</h2>
<div class="lb-trans"><h2>最受欢迎的叙述：低估 9%</h2>
</div><p>The most popular narrative indicates that Aveanna Healthcare Holdings’ fair value is $9.61, slightly above its last close of $8.75. This sets the stage for a deeper look into what may be fueling optimistic analyst projections.</p>
<div class="lb-trans"><p>最受欢迎的叙述表明，Aveanna Healthcare Holdings 的公允价值为 9.61 美元，略高于其最后收盘价 8.75 美元。这为深入探讨可能推动乐观分析师预测的因素奠定了基础。</p>
</div><blockquote>
<p><em>Successful execution of the preferred payer strategy, including a rapid increase in preferred payer agreements in all segments and legislative progress on rate enhancements, supports higher reimbursement rates, better operating leverage, and improved net margins into 2025 and beyond.</em></p>
</blockquote>
<div class="lb-trans"><blockquote>
<p><em>成功执行优先支付者战略，包括在所有细分市场快速增加优先支付者协议以及在费率提升方面的立法进展，支持更高的报销率、更好的运营杠杆和改善的净利润率，直至 2025 年及以后。</em></p>
</blockquote>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>阅读完整叙述。</p>
</div><p>Want to discover what powers this bold valuation? The most closely watched assumption is a multi-year boost to profits and margins, hinging on strategic changes and a big demographic trend. What does this blueprint look like for the next three years? Only the full narrative reveals how these expectations translate to future cash flow and valuation.</p>
<div class="lb-trans"><p>想要了解是什么推动了这个大胆的估值吗？最受关注的假设是利润和利润率的多年度提升，这依赖于战略变化和一个重要的人口趋势。未来三年的蓝图是什么样的？只有完整的叙述才能揭示这些预期如何转化为未来的现金流和估值。</p>
</div><p><strong>Result: Fair Value of $9.61 (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：公允价值为 9.61 美元（低估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整阅读叙述，了解预测背后的原因。</p>
</div><p>However, persistent wage inflation or regulatory pressures on Medicare and Medicaid could still threaten Aveanna’s margin expansion and long-term growth outlook.</p>
<div class="lb-trans"><p>然而，持续的工资通胀或对医疗保险和医疗补助的监管压力仍可能威胁到 Aveanna 的利润扩张和长期增长前景。</p>
</div><p>Find out about the key risks to this Aveanna Healthcare Holdings narrative.</p>
<div class="lb-trans"><p>了解影响 Aveanna Healthcare Holdings 叙述的关键风险。</p>
</div><h2>Another View: What Does the Market Multiple Suggest?</h2>
<div class="lb-trans"><h2>另一种观点：市场倍数暗示了什么？</h2>
</div><p>Looking from a different angle, Aveanna trades at a price-to-earnings ratio of 24.2x, which is a premium over the US Healthcare industry average of 21.5x but remains far below the peer average of 81.6x. Interestingly, the fair ratio for the stock is estimated at 33.5x, a level markets could shift toward if optimism holds. This presents investors with a mix of valuation risk and opportunity, raising the question: will Aveanna’s earnings growth justify a move closer to that fair ratio?</p>
<div class="lb-trans"><p>从另一个角度看，Aveanna 的市盈率为 24.2 倍，虽然高于美国医疗行业平均水平 21.5 倍，但仍远低于同行平均水平 81.6 倍。有趣的是，该股的公允倍数估计为 33.5 倍，如果乐观情绪持续，市场可能会向这一水平转变。这为投资者提供了估值风险和机会的混合，提出了一个问题：Aveanna 的盈利增长是否能证明向该公允倍数靠近的合理性？</p>
</div><p>See what the numbers say about this price — find out in our valuation breakdown.</p>
<div class="lb-trans"><p>查看数字对这一价格的看法——在我们的估值分析中了解更多。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bc590ca0-25cc-402c-81a6-671b1cea62d8/chart/pe-multiple-vs-industry" alt="" original-src="https://images.simplywall.st/company/bc590ca0-25cc-402c-81a6-671b1cea62d8/chart/pe-multiple-vs-industry"/></p>
<p>NasdaqGS:AVAH PE Ratio as at Nov 2025</p>
<div class="lb-trans"><p>NasdaqGS:AVAH 截至 2025 年 11 月的市盈率</p>
</div><h2>Build Your Own Aveanna Healthcare Holdings Narrative</h2>
<div class="lb-trans"><h2>构建您自己的 Aveanna Healthcare Holdings 叙述</h2>
</div><p>If you see the story differently, or want to put your own perspective to the test, you can build a personalized narrative from the same data set in under three minutes, and Do it your way</p>
<div class="lb-trans"><p>如果您对这个故事有不同的看法，或者想要测试自己的观点，您可以在不到三分钟的时间内从相同的数据集中构建个性化叙述，按您的方式进行。</p>
</div><p>A great starting point for your Aveanna Healthcare Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.</p>
<div class="lb-trans"><p>进行 Aveanna Healthcare Holdings 研究的一个很好的起点是我们的分析，强调了 2 个关键奖励和 1 个重要警示信号，这可能会影响您的投资决策。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>Smart investors know opportunities do not wait. Use the Simply Wall Street Screener to pinpoint stocks with standout qualities that could power your portfolio higher.</p>
<div class="lb-trans"><p>聪明的投资者知道机会不会等待。使用 Simply Wall Street 筛选器来精准定位具有突出品质的股票，这些股票可能会推动您的投资组合上涨。</p>
</div><ul>
<li>Unlock profit potential by targeting these 881 undervalued stocks based on cash flows, which the market may be overlooking based on their strong cash flows and fundamentals.</li>
<li>Boost your passive income strategy with these 16 dividend stocks with yields &gt; 3% that offer reliable yields above 3 percent and robust financial health.</li>
<li>Get ahead of tomorrow’s tech trends by tracking these 25 AI penny stocks, companies innovating at the cutting edge of artificial intelligence and automation.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过针对这些 881 只低估股票来解锁利润潜力，这些股票基于现金流被市场忽视，尽管它们的现金流和基本面强劲。</li>
<li>通过这些 16 只收益率超过 3% 的股息股票来提升您的被动收入策略，这些股票提供可靠的收益和强健的财务健康。</li>
<li>通过跟踪这些 25 只 AI 小盘股，抢占明天的科技趋势，这些公司在人工智能和自动化的前沿进行创新。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也不考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 对提到的任何股票没有持仓。</em></p>
</div>

Aveanna Healthcare Holdings (AVAH)：在第三季度业绩强劲且上调指引后评估其估值